Directorate Change

RNS Number : 8884G

Reckitt Benckiser Group PLC

29 July 2019

 

                                                                                                            29 July 2019

DIRECTORATE CHANGE:

Mary Harris: Appointment as designated Non-Executive Director

Reckitt Benckiser Group plc is pleased to announce the appointment of Mary Harris, as designated Non-Executive Director, for engagement with the Company's workforce, in line with the provisions of the UK Corporate Governance Code 2018 (the "Code"), with effect from 26 July 2019.

Mary joined the Board in February 2015 and currently sits on the Nomination and Remuneration Committees, chairing the latter.

There are no additional details relating to the appointments that are required to be disclosed pursuant to Listing Rule 9.6.11(3).

For further Information:
Rupert Bondy

Company Secretary

Tel [phone]

Richard Joyce

SVP, Investor Relations

Tel. [phone]

About RB:

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes. 

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick. 

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide. 

For more information visit www.rb.com

 *RB is the trading name of the Reckitt Benckiser group of companies

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

END

 

 

BOAPGUPWMUPBGUQ